6 best EDC platforms for GDPR compliance in European clinical trials in 2026

When a regulatory authority requests access to your trial data, the clock starts immediately. For studies running across EU member states, that pressure compounds: you need clean audit trails, documented data provenance, and a data processing agreement that satisfies Article 28 of the General Data Protection Regulation (GDPR) — all before the inspector arrives. Viedoc's EDC software is built for exactly this environment, with EU Annex 11 compliance, GDPR-aligned data processing infrastructure, and its Viedoc Inspection Readiness Packet (VIRP) available to every customer. This comparison reviews six leading electronic data capture (EDC) platforms for their GDPR posture, EU Annex 11 alignment, audit trail depth, and suitability for European commercial trials.

Running trials under GDPR means more than ticking a compliance box at sign-off. Your EDC platform processes special categories of personal data on behalf of participants across multiple member states, each with its own supervisory authority and data residency expectations. Every amendment, every query resolution, every user access event is a data processing activity that must be traceable, attributable, and reproducible on demand.

Enterprise platforms designed primarily for US-market submissions can leave European teams carrying the gap between FDA-oriented validation toolkits and the specific requirements of EU Annex 11 and EU Clinical Trials Regulation (EU CTR). The platforms reviewed below are evaluated on the evidence they provide for GDPR compliance, Annex 11 computerized systems validation (CSV), audit trail integrity, and data residency options — the criteria European QA and data management teams actually put to vendors at shortlist stage.

Best EDC solutions for GDPR compliance in European clinical trials: quick comparison

These six EDC platforms represent the most evaluated options for European sponsors and CROs running GDPR-regulated commercial trials, reviewed across GDPR compliance posture, EU Annex 11 alignment, audit trail depth, data residency, and inspection readiness.

1. Viedoc

Viedoc's EDC software is designed for the compliance requirements European trial teams face at every stage of the study lifecycle. It is fully compliant with GDPR and EU Annex 11 and is ISO 27001 and SOC 2 Type II certified, with all data hosted on Microsoft Azure infrastructure. Across 7,500+ completed studies in 75+ countries, the platform has supported teams through FDA and EMA inspections, and every customer receives the VIRP — a structured, inspection-ready documentation package that covers computer system validation, audit trail completeness, and data integrity evidence.

For QA and CSV teams navigating Annex 11 requirements, Viedoc provides a no-code study designer that keeps configuration in-house without creating unvalidated customizations. Amendments are handled directly by certified data managers using Viedoc Designer, with full audit trail coverage at every change point — no vendor-side programmer required, and no gap in the validation chain. The VIRP consolidates the evidence your QA team needs to demonstrate system qualification rather than building it from scratch.

Viedoc is compliant with GDPR, EU Annex 11, EMA GCP, FDA 21 CFR Part 11, HIPAA, and ICH E6. It carries ISO 27001 and SOC 2 Type II certification and is available in 40+ languages across 75+ countries, with 99.99% platform uptime and 24/7 customer success support.

"My experience with Viedoc has been excellent. The database is very customizable and has been able to meet the needs of each of our studies. I am most impressed by the usability of the ePRO system and the extremely high compliance that we have been able to reach using the platform. Customer Support has been excellent with quick turnarounds and response time." — Amanda M., Sr. Clinical Program Manager

Verified proof points:

• Study scale: 7,500+ studies run on Viedoc across 75+ countries
• Compliance: GDPR, EU Annex 11, EMA GCP, FDA 21 CFR Part 11, HIPAA; ISO 27001 and SOC 2 Type II certified
• Inspection readiness: VIRP available to all customers; covers CSV, audit trail, and data integrity documentation
• Uptime: 99.99% platform uptime; hosted on Microsoft Azure
• No-code designer: Studies configured in-house by certified data managers; full audit trail on all amendments
• Support: 24/7 support across global offices; not a ticket-only model

2. Medidata

Medidata offers Rave EDC, the most widely deployed EDC system in large pharmaceutical and global CRO organizations. Rave EDC is part of the Medidata Platform and includes a GDPR-ready data processing exhibit alongside a Unified Protection Strategy that integrates information security, data privacy, and quality management under a single governance framework. Medidata holds ISO 27001 certification, ISO 27701 privacy certification, SOC 2+ reporting, and FISMA compliance, and publishes a biannual SOC 2+ report prepared by PricewaterhouseCoopers.

Medidata performs over 30,000 mid-study changes annually across its customer base, with documentation that all changes are tracked for audit purposes and can be executed without system downtime. The platform supports eSource and electronic health record (EHR) integration, and includes eConsent, eCOA, and RTSM modules within the unified Medidata Platform. For European data residency, Medidata operates infrastructure in Frankfurt, Germany, as an alternate processing site.

Study build timelines for Rave EDC are more extensive than those of no-code alternatives, and Medidata's pricing and professional services model is oriented toward large pharma and global Phase III programs rather than SMID sponsors or CROs running multiple concurrent smaller studies.

3. Veeva Vault EDC

Veeva offers Vault EDC as a module of the Veeva Vault Clinical Data Management System (CDMS), a cloud-based platform that also includes CTMS, eTMF, and eSource. Vault EDC supports drag-and-drop study design and enables mid-study amendments without data migrations. For organizations subject to French HDS (Hébergeur de Données de Santé) requirements, Veeva offers EEA-based data storage options across several Vault applications including Vault EDC. Six of the top 20 pharmaceutical companies have selected Vault EDC as their standard for new trials, and CROs including SGS Health Science use Vault EDC for Phase I through Phase IV studies.

Vault EDC integrates with Veeva CTMS to provide a unified data flow across clinical operations. The platform is part of the Veeva Vault Clinical Suite and supports GDPR compliance through EU-approved standard contractual clauses and the EU-US Data Privacy Framework. Teams considering Vault EDC should account for the broader Vault platform context: the highest value of Veeva's suite model is realized when multiple Vault applications are deployed together, which may represent more infrastructure investment than a single-module EDC requirement warrants.

4. Castor EDC

Castor EDC is a cloud-native EDC platform founded in Amsterdam in 2012, validated for FDA 21 CFR Part 11, GDPR, EU Annex 11, ICH E6(R3) GCP, and EU MDR 2017/745 for post-market clinical follow-up (PMCF) studies. It offers data center options in the Netherlands (EU), United Kingdom, and United States, enabling data residency in the EEA for studies with strict localization requirements. Castor has appointed a dedicated data protection officer and operates under a privacy-by-design model, with a comprehensive Data Processing Agreement available to all customers.

The platform supports five integrated modules — EDC, eCOA, eConsent, Catalyst (AI-assisted EMR data extraction), and Castor Essentials for smaller studies — all on a single cloud-native platform. Castor holds ISO 9001 and ISO 27001 certification and undergoes regular security audits and validation testing. The platform serves pharmaceutical companies, biotech organizations, CROs, and medical device manufacturers across 171 countries, with a particular footprint in European commercial and investigator-initiated trials.

5. Medrio

Medrio offers Medrio CDMS/EDC, a no-code electronic data capture platform designed for sponsors and CROs running Phase I through post-market studies. For GDPR compliance, Medrio has certified to the EU-US Data Privacy Framework through the US Department of Commerce and makes EU Model Clauses available upon request for data transfers outside the European Economic Area. The platform is SOC 2 Type II audited and compliant with FDA 21 CFR Part 11, ICH E6(R2), HIPAA, and GDPR. Medrio maintains infrastructure on Google Cloud Platform across multiple facilities in the US, EU, and China, providing regional redundancy and EU data routing options.

Medrio CDMS/EDC supports no-code, point-and-click eCRF builds that allow study teams to configure and amend studies without specialist programmers. The platform integrates ePRO/eCOA, eConsent, and eTMF modules, and Medrio reports a 98% customer retention rate across its user base. The platform is designed for MedTech, biotechnology, pharmaceutical, and CRO organizations from early feasibility through pivotal and post-marketing studies.

6. OpenClinica

OpenClinica offers a cloud-based EDC platform compliant with FDA 21 CFR Part 11, EU Annex 11, GDPR, and HIPAA, with ISO 27001 and SOC 2 certification. The platform has been used in 10,000+ studies across pharmaceutical companies, CROs, and government agencies including drug, device, and diagnostic trials in regulated commercial contexts. OpenClinica publishes GDPR-specific compliance documentation, including a Data Processing Agreement and FAQ detailing its obligations as a data processor under Article 28, and has appointed processes to support data subject access requests in line with GDPR rights.

The OpenClinica platform includes modules for eCOA, eConsent, randomization, EHR-to-EDC data integration, and reporting, available as a modular or integrated stack. Studies can be published in hours using templated case report forms (CRFs) and one-click publishing, with 24/5 support available to customers. OpenClinica positions its EDC as an alternative to enterprise complexity for sponsors and CROs that need validated compliance without large-enterprise overhead.

What to look for in EDC solutions for GDPR compliance in European clinical trials

Article 28 data processing agreements and controller-processor accountability

When you deploy an EDC platform in a GDPR-regulated trial, the platform vendor becomes your data processor and you, as the sponsor or CRO, retain the role of data controller. That means Article 28 of GDPR requires a binding Data Processing Agreement (DPA) with the vendor that specifies exactly what data is processed, under what legal basis, with what safeguards, and with what rights of audit. A compliant EDC vendor should provide a DPA as a standard contractual document, not as a negotiated add-on. Beyond the DPA itself, look for evidence that the vendor has mapped all sub-processors (hosting providers, analytics tools, support platforms) and that those sub-processors are contractually bound to equivalent standards. Gaps in the sub-processor chain are a common finding in regulatory inspections of software-as-a-service (SaaS) trial systems.

EU Annex 11 computerized systems validation documentation

EU Annex 11 governs the validation, operation, and change control of computerized systems used in regulated clinical trials in European member states. Validation is not a one-time event — it must be maintained across the system lifecycle, documented for each study, and demonstrable on demand. Best-in-class EDC platforms provide customers with a pre-qualified validation documentation package that covers the vendor's own system qualification alongside templates for the customer's operational qualification and performance qualification phases. This substantially reduces the CSV workload for each new study deployment. The alternative is building validation documentation from scratch for every study — a significant resource burden for teams running multiple concurrent trials. Viedoc's VIRP is an example of this approach: structured inspection-ready documentation provided to all customers, not just enterprise accounts.

Audit trail depth and ALCOA-C compliance

GDPR's data integrity requirements and EU Annex 11's audit trail provisions both converge on the same standard: every data entry, modification, and deletion must be attributable, legible, contemporaneous, original, and accurate — the ALCOA-C principles that regulatory agencies apply when reviewing electronic records. An audit trail that captures only final values is insufficient. Your EDC must record who changed what, from what previous value, at what time, and with what user credentials — and that record must be tamper-proof and retrievable in an inspection context. Review how the platform handles amendment versioning: when a protocol amendment triggers database changes, does the audit trail preserve the continuity from the previous version? Does it capture the authorization event? These details matter to inspectors and are worth testing during the user acceptance testing (UAT) phase before go-live.

Data residency and EEA transfer controls

GDPR restricts transfers of personal data to countries outside the European Economic Area unless adequate safeguards are in place. For clinical trial data, this means you need to understand exactly where patient data is stored, processed, and backed up — and whether any of those locations fall outside the EEA. Adequate transfer mechanisms include the EU-US Data Privacy Framework, standard contractual clauses, and binding corporate rules. Vendors that host exclusively on US-based infrastructure without EEA data routing options will require additional contractual and risk management steps to satisfy GDPR Chapter V requirements. If your study design or sponsor agreement requires data residency within the EEA, confirm this is a configurable option before contracting.

Security certification breadth

ISO 27001 sets the baseline for information security management and is necessary but not sufficient for clinical trial contexts. Look for ISO 27001 in combination with SOC 2 Type II — the latter provides independent attestation that security controls were operating effectively over a defined period, not just designed correctly at a point in time. For vendors handling personal health data processed in the context of EU Annex 11 computerized systems, ISO 9001 quality management certification is also meaningful, as it governs the systematic approach to how software changes, releases, and incident management are handled. Vendors holding all three — ISO 27001, SOC 2 Type II, and ISO 9001 — provide the strongest documentable basis for supplier qualification in a European GCP context.

How to choose the right EDC solution for GDPR compliance in European clinical trials

Step 1: Define your data residency requirements before shortlisting

Not all sponsors or regulatory agreements require EEA data residency, but some do — and this requirement effectively eliminates vendors without EU infrastructure options. Before building your shortlist, confirm with your legal and compliance team whether residency is a contractual or regulatory requirement for your specific study portfolio. If it is, your shortlist narrows immediately to platforms offering configurable EEA data routing, and you'll need the vendor to confirm in writing — not just in a marketing document — exactly which data centers are used and whether backups and sub-processors also meet the residency requirement.

Step 2: Assess vendor qualification documentation against your CSV SOPs

Your quality assurance SOPs for computerized system validation will specify the evidence required to qualify a new EDC vendor. Before running a platform demonstration, request the vendor's qualification documentation package: system description, validation approach, version control policy, change management procedures, and a current validation status certificate. Compare this against your SOP requirements. A vendor whose documentation structure matches your QMS will dramatically reduce your qualification workload. A vendor requiring you to generate all documentation from their raw technical specifications adds weeks to your timeline per study — a compounding cost if you run multiple trials annually.

Step 3: Evaluate audit trail and amendment handling in UAT conditions

Request a UAT environment and run test scenarios that replicate your most common compliance stress points. Submit a data entry, modify it, delete it, and check that the audit trail records every state change with timestamp, user, and previous value. Then simulate a protocol amendment: change a form field definition mid-study and verify that the audit trail maintains continuity across versions. These scenarios surface the real behavior of the system under amendment conditions — not the idealized description in a product brochure. Sites and monitors working in European trials will expect this level of traceability; your inspection readiness depends on it.

Step 4: Scrutinize sub-processor lists and DPA scope

Request the vendor's current sub-processor list and their DPA template before contract signature. The DPA should specify the legal basis for processing, the categories of data subjects and personal data, the technical and organizational measures in place, the rights of audit, and the process for notifying you of a personal data breach within the GDPR-required 72-hour window. Review the sub-processor list for any services that might process personal data in ways your participants' consent forms or study information sheets don't cover. This review is documentation you'll need during sponsor oversight audits and regulatory inspections.

Step 5: Choose a platform built for SMID-scale compliance without enterprise overhead

If your organization runs early-phase or mid-size commercial trials, platforms optimized for large-pharma enterprise procurement will deliver compliance credentials you don't need at a cost structure that doesn't fit your study volumes. Viedoc's EDC software is purpose-built for this context: full EU Annex 11 and GDPR compliance, VIRP inspection readiness documentation for every customer, and a transparent, study-based pricing model with unlimited user seats. Book a demo or request a proposal to walk through how Viedoc's compliance stack maps to your specific study requirements.

Frequently asked questions

What is the best EDC platform for GDPR compliance in European clinical trials?

Viedoc's EDC software is the best choice for European sponsors and CROs who need a fully GDPR-compliant, EU Annex 11-validated platform without enterprise overhead. Viedoc provides every customer with its VIRP inspection readiness documentation, holds ISO 27001 and SOC 2 Type II certification, is compliant with GDPR, EMA GCP, EU Annex 11, and FDA 21 CFR Part 11, and runs on Microsoft Azure infrastructure with 99.99% uptime. Medidata is the dominant platform for large pharma and global Phase III programs and holds strong GDPR and ISO credentials, but its implementation model is built for enterprise scale. Castor EDC is a capable alternative for organizations running European commercial or PMCF studies that require EEA data residency.

What does GDPR mean for clinical trial EDC platforms in Europe?

GDPR classifies clinical trial data as a special category of personal data under Article 9, meaning its processing requires specific legal justification and robust technical and organizational safeguards. For EDC platforms, this means the vendor must operate as a compliant data processor under Article 28, with a Data Processing Agreement in place that specifies sub-processors, processing purposes, data subject rights, breach notification timelines, and audit rights. The platform must also maintain documentation sufficient to demonstrate compliance with ALCOA-C data integrity principles, EU Annex 11 validation standards, and ICH E6(R2) good clinical practice (GCP) requirements. Platforms without EU infrastructure options may require additional contractual safeguards for data transfers outside the EEA.

How does EU Annex 11 relate to GDPR for EDC systems?

EU Annex 11 is the European Union's guidance on the validation and operation of computerized systems used in GMP- and GCP-regulated manufacturing and clinical research. It sets the framework for computer system validation (CSV), change control, audit trails, data backup, and incident management. GDPR adds a data protection layer on top of those operational requirements: the same systems that must satisfy Annex 11 for data integrity and traceability purposes must also satisfy GDPR for personal data processing, consent management, and data subject rights. An EDC platform that is Annex 11-validated but lacks GDPR-aligned data processing agreements and breach notification processes is non-compliant for European commercial trials. The two frameworks are complementary, not interchangeable.

How long does it take to validate and deploy an EDC platform for a European trial?

Validation and deployment timelines depend heavily on the platform's approach to computerized system qualification documentation. On platforms that provide pre-qualified validation packages — covering system description, validation approach, and change management procedures — in-house CSV teams can work in parallel with study build rather than sequentially after it. On platforms that require customers to generate all validation documentation from scratch, the qualification phase can add four to eight weeks to a study go-live timeline. Modern no-code platforms with structured qualification documentation, like Viedoc's EDC, typically achieve go-live in as few as eight weeks, including validation activities. Enterprise platforms with programmer-dependent build models and less structured CSV packages can extend this significantly.

What certifications should I look for in an EDC vendor supplying European clinical trials?

At minimum, require ISO 27001 for information security management, SOC 2 Type II for independent attestation of security controls over time, and evidence of EU Annex 11 compliance through a validated system qualification package. ISO 9001 quality management certification is a meaningful additional indicator for GCP contexts. For GDPR specifically, look for a current Data Processing Agreement template, a published sub-processor list, EU infrastructure or EEA data routing options, and a documented breach notification process. Vendors holding EU-US Data Privacy Framework certification provide a recognized legal mechanism for transfers to US-based infrastructure. All certifications should be current — ask for certificate validity dates, not just the certification name.

What is the Viedoc Inspection Readiness Packet (VIRP)?

The Viedoc Inspection Readiness Packet (VIRP) is a structured documentation package provided to all Viedoc customers to support computer system validation and regulatory inspection preparation. It covers the technical and operational evidence required to demonstrate that Viedoc's EDC meets the requirements of EU Annex 11, FDA 21 CFR Part 11, and ICH E6 for computerized systems used in regulated clinical trials. Rather than building inspection documentation from raw system specifications, Viedoc customers receive a pre-structured package that maps directly to the regulatory framework, substantially reducing the time and resource burden of CSV activities for each new study. The VIRP is available as a standard feature of the Viedoc platform, not an add-on service.

Making the right EDC choice for GDPR compliance in European clinical trials

The EDC market in Europe has matured around a shared baseline: all serious commercial platforms now offer GDPR compliance documentation and EU Annex 11 alignment as standard, not as differentiators. The global eClinical software market was estimated at over $11 billion in 2025 and is growing at approximately 14% annually, with European spend representing around 24% of the total. What actually differentiates platforms at shortlist stage is the depth and usability of the compliance evidence they provide — how much of the CSV and inspection-readiness work they absorb versus how much they leave to the customer.

Your decision should map to your organizational profile. EU-based QA and compliance stakeholders typically weight certification breadth, audit trail depth, and vendor stability more heavily than speed metrics alone. US organizations running EU trials need to confirm EEA data routing options and sub-processor compliance. Teams running multiple concurrent SMID studies prioritize how quickly they can qualify and deploy each new study; the validation overhead per study compounds across a portfolio. For organizations weighing vendor consolidation across EDC, ePRO, and eTMF, integrated suite platforms reduce the number of DPAs, sub-processor lists, and system qualifications to manage.

Platform switching in a regulated environment carries significant validation burden — re-qualification of the new system, migration of historical data, and retraining of sites and data management teams. Choosing carefully at the outset, based on the compliance evidence and support infrastructure you actually need, avoids a compounding cost that grows with every study added to an incompatible platform.

Why Viedoc is the best EDC choice for GDPR compliance in European clinical trials

For European sponsors and CROs running commercial trials under GDPR and EU Annex 11, Viedoc's EDC software delivers the compliance depth and inspection-readiness infrastructure that QA and data management teams need at every stage of the study lifecycle. With ISO 27001 and SOC 2 Type II certification, full EU Annex 11 and GDPR compliance, EMA GCP and FDA 21 CFR Part 11 alignment, and 99.99% uptime on Microsoft Azure, Viedoc provides a documentable, audit-ready foundation that holds up under regulatory scrutiny.

What makes Viedoc operationally different is that inspection readiness is not an add-on. Every customer receives the VIRP, giving your QA team a structured qualification documentation package rather than a pile of raw technical specifications to work from. The no-code Designer means your data managers handle amendments in-house, with a complete audit trail at every change point — no vendor dependency, no CSV gap, no delay waiting for a programmer to become available. Viedoc's transparent, study-based pricing model with unlimited user seats makes the total cost of compliance predictable across your study portfolio, without per-seat fees that penalize headcount growth.

Viedoc has supported 7,500+ studies in 75+ countries since 2003, across 140,000+ users and 1.6 million trial participants. Its compliance stack covers GDPR, EU Annex 11, EMA GCP, FDA 21 CFR Part 11, HIPAA, and ICH E6, with 24/7 customer success support and a tiered CRO Partner Program for organizations managing multi-sponsor portfolios.

If you're building or evaluating your EU compliance stack and want to see how Viedoc maps to your specific study requirements — audit trail depth, validation documentation, GDPR data processing terms, or multi-country language support — book a demo or request a proposal.